Treatment of shigellosis with poteseptyl (trimethoprim+superseptyl).
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D004338:Drug Combinations; D004405:Dysentery, Bacillary / Q000188:drug therapy* / Q000382:microbiology; D005243:Feces / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D012760:Shigella / Q000187:drug effects; D012763:Shigella flexneri / Q000302:isolation & purification; D012764:Shigella sonnei / Q000302:isolation & purification; D013418:Sulfamethazine / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D013418:Sulfamethazine; C009095:superseptyl (sulfamethazine), trimethoprim drug combination; D014295:Trimethoprim